Back

Hepatic t1 mapping: a new easily obtained biomarker for heart failure patients undergoing cardiac magnetic resonance.

10 May 2023 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Dechiphering the phenotypes and dynamics of cardiomyopathies under the light of multi-modality imaging T1 and T2 Mapping EACVI Premium Access EACVI 2023

About the speaker

Photo
Doctor Rita Reis Santos

Hospital Santa Cruz, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping
Doctor A. Ioannou (Greater London, GB)
Abstract Slides Video
Presentation thumbnail
Prospective cascade screening for transthyretin amyloid cardiomyopathy in patients undergoing spinal stenosis surgery: results of the CASS (Cardiac Amyloidosis in Spinal Stenosis) study.
Doctor P. Debonnaire (Brugge, BE)
Abstract Slides Video
Presentation thumbnail
Dapagliflozin improves radial and longitudinal strain, increases pAMPK and reduces myocardial and renal NF-kB expression in preclinical models of doxorubicin cardiotoxicity through NLRP3 and Myd-88
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Impact of myocardial inflammation on quantitative myocardial perfusion at long-term follow-up - a descriptive hybrid PET/MR myocarditis study
Professor R. Buechel (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance phenotypes and cardiovascular prognosis in classical vs cardiac variant of Fabry disease
Doctor G. Guida (San Donato Milanese, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Dechiphering the phenotypes and dynamics of cardiomyopathies under the light of multi-modality imaging
Video

The Event

Event poster

EACVI 2023

10 May - 12 May 2023
You may be interested in
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging in the work-up and management of cardiac amyloidosis
thumbnail
Congress Presentation
CMR in acute coronary syndrome: optional or essential? - discussion
thumbnail
Congress Presentation
Magnetic resonance imaging is the way to go for risk assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources